As of May 27
| +0.34 / +0.44%|
The 19 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 70.00, with a high estimate of 85.00 and a low estimate of 58.00. The median estimate represents a -10.46% decrease from the last price of 78.18.
The current consensus among 25 polled investment analysts is to Hold stock in St. Jude Medical. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.